Kascaid
Immune Monitoring Biosensor Platform
San Francisco, United States · Founded 2024 · $2.3M raised
- Headquarters
- San Francisco, California
- Founded
- 2024
- Business Model
- B2B
- Website
- kascaid.bio
- Total Funding
- $2.3M
- Last Round
- $2.3M Pre-SeedJul 2025
- Rounds
- 1
About
Develops interstitial fluid biosensors for real-time immune monitoring and molecular diagnostics at the point of care.
Summary
Kascaid is a Biotech company based in San Francisco, United States, founded in 2024. It has raised $2.3M in total across 1 round, most recently a $2.3M Pre-Seed round in Jul 2025. Investors include Boost VC, 2048 Ventures and Spacecadet Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jul 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...